Home › Funds › Kiltearn Partners LLP › CVS

Kiltearn Partners LLP position in CVS

CVS HEALTH CORP · Consumer Staples

Kiltearn Partners LLP reported holding 344,789 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$29.5M, representing 7.11% of its reported portfolio and ranking #3 among its reported holdings. Kiltearn Partners LLP has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)344.79K sh
Reported value held$29.54M
Portfolio Weight7.11%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Kiltearn Partners LLP's CVS position evolved

Kiltearn Partners LLP first disclosed a stake in CVS in Q3 2023 at 1,008,468 shares (US$70.4M). The position peaked in Q4 2023 at 987,808 shares, worth US$78.0M. Across 13 filings, Kiltearn Partners LLP increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 344,789 shares valued at US$29.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.01M $70.41M New
Q4 2023 987.81K $78.00M Reduce
Q1 2024 861.17K $68.51M Reduce
Q2 2024 791.67K $46.76M Reduce
Q3 2024 716.87K $45.08M Reduce
Q4 2024 648.37K $29.11M Reduce
Q1 2025 553.17K $37.48M Reduce
Q2 2025 521.67K $35.98M Reduce
Q3 2025 530.17K $39.97M Add
Q4 2025 441.77K $35.06M Reduce
Q1 2026 365.07K $26.22M Reduce
Q2 2026 345.47K $35.74M Reduce
Q3 2026 344.79K $29.54M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Kiltearn Partners LLP held CVS?

Kiltearn Partners LLP has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Kiltearn Partners LLP's current position in CVS?

As of Q3 2026, Kiltearn Partners LLP holds 344.79K shares of CVS (CVS HEALTH CORP), valued at $29.54M, representing 7.11% of its reported portfolio and ranking #3.

Has Kiltearn Partners LLP been buying or selling CVS?

In the latest 13F filing (Q3 2026), Kiltearn Partners LLP held unchanged its position in CVS. The position peaked in Q4 2023 at 987.81K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.